APVO Market Cap History
Below is a table of the APVO market cap history going back to 8/1/2016:

Date APVO Market Cap
8/1/201658.46M
11/1/201642.52M
3/24/201738.07M
5/10/201743.67M
8/8/201736.84M
11/6/201766.64M
3/9/201866.08M
5/8/201895.09M
8/7/2018102.24M
11/9/201876.23M
3/14/201936.50M
5/7/201936.34M
8/6/201941.49M
8/13/20191.44M
11/6/201928.75M
3/25/202012.86M
3/27/202012.90M

Also see: APVO Shares Outstanding History
and APVO YTD Return
APVO Historical Market Cap:
-33.86% CAGR
APVO Historical Market Cap: +-33.86% CAGR

Mouse over chart for data details
8/1/2016 ...3/27/2020
Aptevo Therapeutics is a clinical-stage biotechnology company focused on developing immunotherapies for the treatment of cancer. Co.'s lead clinical candidate, APVO436 is an ADAPTIR bispecific immunotherapeutic protein targeting CD123, a cell surface receptor highly expressed on several hematological malignancies and CD3, a component of the T-cell receptor. ALG.APV-527 is an investigational bispecific ADAPTIR candidate, partnered with Alligator Bioscience AB, featuring a mechanism of action designed to simultaneously target 4-1BB (CD137) and 5T4, a tumor antigen overexpressed in a number of different types of cancer. APVO603 is a preclinical dual agonist bispecific ADAPTIR candidate. We show 17 historical shares outstanding datapoints in our APVO shares outstanding history coverage, used to compute APVO market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing APVO market cap history over the course of time is important for investors interested in comparing APVO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of APVO versus a peer is one thing; comparing APVO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like APVO can fluctuate over the course of history. With this page we aim to empower investors researching APVO by allowing them to research the APVO market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for APVO:
APVO SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aptevo Therapeutics (APVO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AQB Market Cap History
AQXP Market Cap History
ARA Market Cap History
ARAY Market Cap History
ARDM Market Cap History
ARDX Market Cap History
ARNA Market Cap History
ARQL Market Cap History
ARRY Market Cap History
ARWR Market Cap History
More Healthcare companies »

 

APVO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.